The DOI matches its Crossref record; 57 of the 60 references it cites were found in a registry or an index.
Suppression of two major Fragile X Syndrome mouse model phenotypes by the mGluR5 antagonist MPEP
Abstract
Fragile X Syndrome is the most common form of inherited mental retardation worldwide. A Fragile X mouse model, fmr1(tm1Cgr), with a disruption in the X-linked Fmr1 gene, has three substantial deficits observed in several strains: (1) sensitivity to audiogenic seizures (AGS), (2) tendency to spend significantly more time in the center of an open field, and (3) enlarged testes. Alterations in metabotropic glutamate receptor group I signaling were previously identified in the fmr1(tm1Cgr) mouse. In this study, we examined the effect of MPEP, an antagonist of the group I metabotropic glutamate receptor mGluR5, on audiogenic seizures and open field activity of fmr1(tm1Cgr) mice. Genetic analysis revealed synergistic reactions between fmr1(tm1Cgr) and inbred AGS alleles. In addition, AGS sensitivity due to the fmr1(tm1Cgr) allele was restricted during development. Examination of phenotypes combining mGluR5 inhibition and Fmr1 mutation indicated that absence of FMRP may affect mGluR5 signaling through indirect as well as direct pathways. All strains of fmr1(tm1Cgr) mice tested (FVB/NJ, C57BL/6J, and an F1 hybrid of the two) had a more excitable AGS pathway than wild-type, and consequently required more MPEP to achieve seizure suppression. At high doses of mGluR5 antagonists, a Fragile X specific tolerance (loss of drug activity) was observed. The tolerance effect could be overcome by a further increase in drug dose. In open field tests, MPEP reduced fmr1(tm1Cgr) center field behavio…
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Preclinical studies have primarily focused on mGluR5 signaling as potential targets for treatment in adult mice 99,110-113 .”
From Developmental timing and critical windows for the treatment of psychiatric disorders (2016) · cites this paper as [113]
In the citing paper
“have demonstrated that dampening mGluR5 signalling rescues protein synthesis and many of the classic outcome measures (TABLE 1) used in the mouse and fly models30–35.”
From Drug development for neurodevelopmental disorders: lessons learned from fragile X syndrome (2018) · cites this paper as [35]
In the citing paper
“Treatment of Fmr1 KO mice with the mGluR antagonist 2-methyl-6-(phenylethynyl)-pyridine (MPEP) (Figure 3B) resulted in suppression of the audiogenic seizure phenotype (106) and rescue of dendritic spine morphology in the Fmr1 KO mouse (107).”
From Fragile X syndrome: causes, diagnosis, mechanisms, and therapeutics (2012) · cites this paper as [106]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The open field as a paradigm to measure the effects of drugs on anxiety-like behaviors: a review.
Prut, L., & Belzung, C. (2003) · European Journal of Pharmacology · doi:10.1016/s0014-2999(03)01272-x · Cited by 3,190
The open-field test: A critical review.
WALSH, R. N., & Cummins, R. A. (1976) · Psychological Bulletin · doi:10.1037/0033-2909.83.3.482 · Cited by 2,389
The mGluR theory of fragile X mental retardation
Bear, M. F., Huber, K. M., & Warren, S. T. (2004) · Trends in Neurosciences · doi:10.1016/j.tins.2004.04.009 · Cited by 1,580
Pellow, S., & File, S. E. (1986) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(86)90552-6 · Cited by 1,534
Altered synaptic plasticity in a mouse model of fragile X mental retardation
Huber, K. M., Gallagher, S. M., Warren, S. T., & Bear, M. F. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.122205699 · Cited by 1,349
Fmr1 knockout mice: A model to study fragile X mental retardation
THEDUTCHBELGIANFRAGILEXCONSOR (1994) · Cell · doi:10.1016/0092-8674(94)90569-x · Cited by 1,108
Abnormal dendritic spines in fragile X knockout mice: Maturation and pruning deficits
Comery, T. A., Harris, J. B., Willems, P. J., Oostra, B. A., Irwin, S. A., Weiler, I. J., & Greenough, W. T. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.10.5401 · Cited by 1,046
Deficient cerebellar long-term depression and impaired motor learning in mGluR1 mutant mice
Aiba, A., Kano, M., Chen, C., Stanton, M. E., Fox, G. D., Herrup, K., Zwingman, T. A., & Tonegawa, S. (1994) · Cell · doi:10.1016/0092-8674(94)90205-4 · Cited by 930
Metabotropic glutamate receptors: electrophysiological properties and role in plasticity
Anwyl, R. (1999) · Brain Research Reviews · doi:10.1016/s0165-0173(98)00050-2 · Cited by 799
Induction of LTP in the hippocampus needs synaptic activation of glutamate metabotropic receptors
Bashir, Z. I., Bortolotto, Z. A., Davies, C. H., Berretta, N., Irving, A. J., Seal, A., Henley, J. M., Jane, D. E., Watkins, J. C., & Collingridge, G. L. (1993) · Nature · doi:10.1038/363347a0 · Cited by 733
Gasparini, F., Lingenhöhl, K., Stoehr, N., Flor, P. J., Heinrich, M., Vranesic, I., Biollaz, M., Allgeier, H., Heckendorn, R., Urwyler, S., et al. (1999) · Neuropharmacology · doi:10.1016/s0028-3908(99)00082-9 · Cited by 725
Zalfa, F., Giorgi, M., Primerano, B., Moro, A., Di Penta, A., Reis, S., Oostra, B., & Bagni, C. (2003) · Cell · doi:10.1016/s0092-8674(03)00079-5 · Cited by 676
Weiler, I. J., Irwin, S. A., Klintsova, A. Y., Spencer, C. M., Brazelton, A. D., Miyashiro, K., Comery, T. A., Patel, B., Eberwine, J., & Greenough, W. T. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.10.5395 · Cited by 644
Two Distinct Forms of Long-Term Depression Coexist in CA1 Hippocampal Pyramidal Cells
Oliet, S. H. R., Malenka, R. C., & Nicoll, R. A. (1997) · Neuron · doi:10.1016/s0896-6273(00)80336-0 · Cited by 578
Evidence that fragile X mental retardation protein is a negative regulator of translation
Laggerbauer, B. (2001) · Human Molecular Genetics · doi:10.1093/hmg/10.4.329 · Cited by 571
Abnormal Development of Dendritic Spines in FMR1 Knock-Out Mice
Nimchinsky, E. A., Oberlander, A. M., & Svoboda, K. (2001) · The Journal of Neuroscience · doi:10.1523/jneurosci.21-14-05139.2001 · Cited by 560
Analysis of neocortex in three males with the Fragile X syndrome
Hinton, V. J., Brown, W. T., Wisniewski, K., & Rudelli, R. D. (1991) · American Journal of Medical Genetics · doi:10.1002/ajmg.1320410306 · Cited by 527
A multiple-test study of anxiety-related behaviours in six inbred rat strains
Ramos, A., Berton, O., Mormède, P., & Chaouloff, F. (1997) · Behavioural Brain Research · doi:10.1016/s0166-4328(96)00164-7 · Cited by 493
The fragile X mental retardation protein inhibits translation via interacting with mRNA
Li, Z. (2001) · Nucleic Acids Research · doi:10.1093/nar/29.11.2276 · Cited by 448
Long-term synaptic depression in the mammalian brain
Linden, D. J. (1994) · Neuron · doi:10.1016/0896-6273(94)90205-4 · Cited by 446
Bortolotto, Z. A., Bashir, Z. I., Davies, C. H., & Collingridge, G. L. (1994) · Nature · doi:10.1038/368740a0 · Cited by 432
Antar, L. N., Afroz, R., Dictenberg, J. B., Carroll, R. C., & Bassell, G. J. (2004) · The Journal of Neuroscience · doi:10.1523/jneurosci.0099-04.2004 · Cited by 411
Huber, K. M., Roder, J., & Bear, M. F. (2001) · Journal of Neurophysiology · doi:10.1152/jn.2001.86.1.321 · Cited by 390
Adult fragile X syndrome: Clinico-neuropathologic findings
Rudelli, R. D., Brown, W. T., Wisniewski, K., Jenkins, E. C., Laure-Kamionowska, M., Connell, F., & Wisniewski, H. M. (1985) · Acta Neuropathologica · doi:10.1007/bf00687814 · Cited by 362
Fragile X mice develop sensory hyperreactivity to auditory stimuli
Chen, L., & Toth, M. (2001) · Neuroscience · doi:10.1016/s0306-4522(01)00036-7 · Cited by 345
Audiogenic Seizures Susceptibility in Transgenic Mice with Fragile X Syndrome
Musumeci, S. A., Bosco, P., Calabrese, G., Bakker, C., De Sarro, G. B., Elia, M., Ferri, R., & Oostra, B. A. (2000) · Epilepsia · doi:10.1111/j.1528-1157.2000.tb01499.x · Cited by 289
(Over)correction of FMR1 deficiency with YAC transgenics: behavioral and physical features
Peier, A. M. (2000) · Human Molecular Genetics · doi:10.1093/hmg/9.8.1145 · Cited by 285
Todd, P. K., Mack, K. J., & Malter, J. S. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2336265100 · Cited by 280
Spooren, W. P. J. M., Vassout, A., Neijt, H. C., Kuhn, R., Gasparini, F., Roux, S., Porsolt, R. D., & Gentsch, C. (2000) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)39029-9 · Cited by 266
The fra(X) syndrome: Neurological, electrophysiological, and neuropathological abnormalities
Wisniewski, K. E., Segan, S. M., Miezejeski, C. M., Sersen, E. A., & Rudelli, R. D. (1991) · American Journal of Medical Genetics · doi:10.1002/ajmg.1320380267 · Cited by 261
Epilepsy and EEG Findings in Males with Fragile X Syndrome
Musumeci, S. A., Hagerman, R. J., Ferri, R., Bosco, P., Bernardina, B. D., Tassinari, C. A., Sarro, G. D., & Elia, M. (1999) · Epilepsia · doi:10.1111/j.1528-1157.1999.tb00824.x · Cited by 250
A phenotypic and molecular characterization of the fmr1‐tm1Cgr Fragile X mouse
Yan, Q. J., Asafo‐Adjei, P. K., Arnold, H. M., Brown, R. E., & Bauchwitz, R. P. (2004) · Genes, Brain and Behavior · doi:10.1111/j.1601-183x.2004.00087.x · Cited by 213
Self-citationVanderklish, P. W., & Edelman, G. M. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.032681099 · Cited by 200
Varney, M. A., Cosford, N. D. P., Jachec, C., Rao, S. P., Sacaan, A. I., Lin, F., Bleicher, L. S., Santori, E. M., Flor, P. J., Allgeier, H., et al. (1999) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)34881-5 · Cited by 189
RELATIONSHIPS BETWEEN EXPLORATORY BEHAVIOUR AND FEAR: A REVIEW
Russell, P. A. (1973) · British Journal of Psychology · doi:10.1111/j.2044-8295.1973.tb01369.x · Cited by 167
Busse, C. S., Brodkin, J. D., Tattersall, D., Anderson, J. J., Warren, N., Tehrani, L. R., Bristow, L. J., Varney, M. A., & Cosford, N. D. P. (2004) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300540 · Cited by 159
Statistical Concepts for the Behavioral Sciences
Kiess, H. O. (1989) · Framingham State University Digital Repository (Framingham State University) · Cited by 156
Multiple MPEP administrations evoke anxiolytic- and antidepressant-like effects in rats
Pilc, A., Kłodzińska, A., Brański, P., Nowak, G., Pałucha-Poniewiera, A., Szewczyk, B., Tatarczynska, E., Chojnacka-Wójcik, E., & Wierońska, J. M. (2002) · Neuropharmacology · doi:10.1016/s0028-3908(02)00082-5 · Cited by 150
Chapman, A. G., Nanan, K., Williams, M., & Meldrum, B. S. (2000) · Neuropharmacology · doi:10.1016/s0028-3908(99)00242-7 · Cited by 146
Metabotropic glutamate receptors are required for the induction of long-term potentiation
Zheng, F., & Gallagher, J. P. (1992) · Neuron · doi:10.1016/0896-6273(92)90231-2 · Cited by 146
Role of neurosteroids in catamenial epilepsy
Reddy, D. S. (2004) · Epilepsy Research · doi:10.1016/j.eplepsyres.2004.09.003 · Cited by 144
Ossowska, K., Konieczny, J., Wolfarth, S., Wierońska, J. M., & Pilc, A. (2001) · Neuropharmacology · doi:10.1016/s0028-3908(01)00083-1 · Cited by 116
Michelson, H. B., & Lothman, E. W. (1989) · Developmental Brain Research · doi:10.1016/0165-3806(89)90113-2 · Cited by 113
Spooren, W. P. J. M., Gasparini, F., Bergmann, R., & Kuhn, R. R. (2000) · European Journal of Pharmacology · doi:10.1016/s0014-2999(00)00697-x · Cited by 112
Kearney, J. A., Frey, K. A., & Albin, R. L. (1997) · Journal of Neuroscience · doi:10.1523/jneurosci.17-11-04415.1997 · Cited by 89
Induction of LTD by activation of group I mGluR in the dentate gyrus in vitro
Camodeca, N., Breakwell, N. A., Rowan, M. J., & Anwyl, R. (1999) · Neuropharmacology · doi:10.1016/s0028-3908(99)00093-3 · Cited by 85
Activation of glutamate metabotropic receptors induces long-term potentiation
Bortolotto, Z. A., & Collingridge, G. L. (1992) · European Journal of Pharmacology · doi:10.1016/0014-2999(92)90135-q · Cited by 78
Simon, P., Panissaud, C., & Costentin, J. (1994) · Psychopharmacology · doi:10.1007/bf02244990 · Cited by 77
McGeehan, A., Janak, P. H., & Olive, M. F. (2004) · Psychopharmacology · doi:10.1007/s00213-003-1733-2 · Cited by 70
Attarian, S., & Amalric, M. (1997) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.1997.tb01430.x · Cited by 57
Todd, P. K., Malter, J. S., & Mack, K. J. (2003) · Molecular Brain Research · doi:10.1016/s0169-328x(02)00657-5 · Cited by 56
Experience with prenatal fragile X detection
Jenkins, E. C., Brown, W. T., Brooks, J., Duncan, C. J., Rudelli, R. D., Wisniewski, H. M., & Opitz, J. M. (1984) · American Journal of Medical Genetics · doi:10.1002/ajmg.1320170114 · Cited by 48
Differential effects of mGluR1 and mGlur5 antagonism on spatial learning in rats
Petersen, S., Bomme, C., Baastrup, C., Kemp, A., & Christoffersen, G. R. J. (2002) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(02)00829-8 · Cited by 43
The effects of trans-ACPD on long-term potentiation in the rat hippocampal slice
McGuinness, N. J. P., Anwyl, R., & Rowan, M. J. (1991) · Neuroreport · doi:10.1097/00001756-199111000-00014 · Cited by 40
Meeker, D., Kim, J., & Vezina, P. (1998) · Brain Research · doi:10.1016/s0006-8993(98)00941-x · Cited by 22
Nadlewska, A., Car, H., Rj, W., & Wisniewski, K. (2002) · PubMed · Cited by 10
Irwin (2001) · doi:10.1002/1096-8628(20010115)98:2
Cited by
Sorted by citations
Metabotropic Glutamate Receptors: Physiology, Pharmacology, and Disease
Niswender, C. M., & Conn, P. J. (2010) · The Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.011008.145533 · Cited by 1,889
Behavioural phenotyping assays for mouse models of autism
Silverman, J. L., Yang, M., Lord, C., & Crawley, J. N. (2010) · Nature Reviews Neuroscience · doi:10.1038/nrn2851 · Cited by 1,462
Trinucleotide Repeat Disorders
Orr, H. T., & Zoghbi, H. Y. (2007) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.29.051605.113042 · Cited by 1,394
Fragile X Syndrome: Loss of Local mRNA Regulation Alters Synaptic Development and Function
Bassell, G. J., & Warren, S. T. (2008) · Neuron · doi:10.1016/j.neuron.2008.10.004 · Cited by 1,051
Correction of Fragile X Syndrome in Mice
Dölen, G., Osterweil, E., Rao, B. S. S., Smith, G. B., Auerbach, B. D., Chattarji, S., & Bear, M. F. (2007) · Neuron · doi:10.1016/j.neuron.2007.12.001 · Cited by 979
Metadata
- Authors
- Yan, Q. J., Rammal, M., Tranfaglia, M., & Bauchwitz, R. P.
- Affiliations
- Columbia University (US)
- Fraxa Research Foundation (US)
- Corresponding author
- Bauchwitz, R.P.
- ORCID
- Bauchwitz, R.P.
- Venue
- Neuropharmacology
- Publisher
- Elsevier BV
- Published
- 2005-12
- Volume
- 49
- Issue
- 7
- Pages
- 1053-1066
- ISSN
- 0028-3908 (ISSN-L)
- OpenAlex
- W2094993063
- Cited by
- 521
- References
- 60
- Citations by year
- 2026: 6 · 2025: 7 · 2024: 8 · 2023: 10 · 2022: 12 · 2021: 16 · 2020: 13 · 2019: 10 · 2018: 12 · 2017: 28 · 2016: 26 · 2015: 26 · 2014: 30 · 2013: 45 · 2012: 47
- FWCI
- 13.31
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- Locations
- Neuropharmacology (publishedVersion)
- PubMed (publishedVersion)
- CogPrints (University of Southampton) (submittedVersion)
- Funders
- FRAXA Research Foundation
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetics and Neurodevelopmental Disorders
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Health Sciences › Medicine › Clinical Neurology › Epilepsy research and treatment
- Keywords
- fragile X syndrome, FMR1 gene, mGluR5, MPEP, audiogenic seizures, testicular enlargement, FMRP, drug tolerance, seizure susceptibility, mouse model
- MeSH terms
- Aging, Alleles, Animals, Drug Synergism, Exploratory Behavior, Female, Fragile X Syndrome, Genotype, Male, Mice, Inbred C57BL, Phenotype, Pyridines, Receptors, Metabotropic Glutamate, Epilepsy, Reflex, Mice, Fragile X Messenger Ribonucleoprotein 1, Receptor, Metabotropic Glutamate 5
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
